SCHEMBL24252576

SCHEMBL24252576

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccncc5)cc4)cc(-c4ccc(-c5cccnc5)cc4)n3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.60
DHODH Q02127 1/20 0.53
ALDH1A1 P00352 5/20 0.53
MAPT P10636 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
HPGD P15428 3/20 0.53
NTSR1 P30989 1/20 0.53
CYP17A1 P05093 1/20 0.51
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
RAB9A P51151 4/20 0.50
KDM4E B2RXH2 3/20 0.50
CYP3A4 P08684 3/20 0.50
MKNK1 Q9BUB5 1/20 0.50
MKNK2 Q9HBH9 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 3/20 0.49
TP53 P04637 2/20 0.49
HSD17B10 Q99714 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397361 0.95 CYP19A1 (0.55) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL19486723 0.95 CYP19A1 (0.59) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL19397331 0.95 CYP19A1 (0.55) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL19638034 0.95 CYP19A1 (0.66) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL24527291 0.95 CYP19A1 (0.66) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL17945297 0.95 CYP19A1 (0.66) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL19397469 0.94 CYP19A1 (0.54) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL19397432 0.94 CYP19A1 (0.54) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL24589928 0.93 CYP19A1 (0.59) CYP19A1DHODHALDH1A1MAPTMEN1
SCHEMBL19397539 0.93 CYP19A1 (0.56) CYP19A1DHODHALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220052268-A1 COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC29A1, NUDT1, SLC29A2 CYP19A1 2810/4885DHODH 202/4885ALDH1A1 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.